About us

Warneford Partners is a privately owned pharmaceutical company with a focus on the development and marketing of innovative gastrointestinal products.

Product portfolio

A range of naloxone-based medicines and combinations for the treatment of Opioid Induced Constipation (OIC).


Warneford is actively seeking international partners to commercialise elements of the portfolio.